NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing.
The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud computing in NGS for data management and untapped emerging economies are expected to provide new market opportunities to NGS manufacturers in the near future.

Market Analysis and Insights: Global Next Generation Sequencing (NGS) Market
The global Next Generation Sequencing (NGS) market size is projected to reach US$ 8843.5 million by 2027, from US$ 5002 million in 2020, at a CAGR of 8.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Sequencing (NGS) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Sequencing (NGS) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Sequencing (NGS) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Sequencing (NGS) market.

Global Next Generation Sequencing (NGS) Scope and Market Size
Next Generation Sequencing (NGS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Sequencing (NGS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing

Segment by Application
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics
Macrogen